Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia

NCT02203838 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT02203838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02203838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Long-Term Safety and Tolerability Study of RBP-7000 in the Treatment of Subjects With Schizophrenia
Lead sponsor
Indivior Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2014
Completion date
September 30, 2016
Enrollment
500 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia